DCVC Opportunity Fund II GP, LLC
Follow13F filer, CIK 1668343, PALO ALTO, CA
DCVC Opportunity Fund II GP, LLC reported $113,008,415 across 2 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-25-013461
- Period
- 2024-12-31
- Reported value
- $113M
- Holdings
- 2
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 1
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ROCKET LAB USA INCreduced | -3,814,786 | -$97.2M |
| RGTIexited | -1,599,052 | -$1.25M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0001104659-25-013461, largest first. % of portfolio is the value over $113,008,415, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ROCKET LAB USA INCROCKET LAB USA INC | 3,388,249 | $86.3M | 76.36% | -3,814,786 | |||
| RXRXRECURSION PHARMACEUTICALS IN | 3,951,141 | $26.7M | 23.64% | 0 | Timeline |
Sold out in Q4 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| RGTIRIGETTI COMPUTING INC | 1,599,052 | $1.25M | shares |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001104659-25-013461 | base | 2025-02-14 | acceptance time not in the bulk data set |